Lithium NP03 Treatment for Late-Stage Amyloidosis in Rat Model of Alzheimer’s Disease
Written by Angeline A. De Leon, Staff Writer. This study demonstrates how microdose NP03 lithium reduced markers of neuroinflammation and cellular oxidative stress during the post-plaque stage of amyloid pathology in a transgenic rat model of Alzheimer’s disease.